{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:56:13Z","timestamp":1791849373077,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270097"],"award-info":[{"award-number":["82270097"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ60571"],"award-info":[{"award-number":["2025JJ60571"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M753695"],"award-info":[{"award-number":["2024M753695"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"DOI":"10.1007\/s10067-026-08476-2","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T05:22:14Z","timestamp":1791782534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Increased METTL1 expression in B cell subsets correlates with disease activity and immunological features in SLE"],"prefix":"10.1007","author":[{"given":"Fang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7755-7956","authenticated-orcid":false,"given":"Yiying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"issue":"4","key":"8476_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2022.101814","volume":"36","author":"Y Tanaka","year":"2023","unstructured":"Tanaka Y (2023) Systemic lupus erythematosus. Best Pract Res Clin Rheumatol 36(4):101814. https:\/\/doi.org\/10.1016\/j.berh.2022.101814","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"11","key":"8476_CR2","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC202006020","volume":"172","author":"M Kiriakidou","year":"2020","unstructured":"Kiriakidou M, Ching CL (2020) Systemic lupus erythematosus. Ann Intern Med 172(11):ITC81\u2013ITC96. https:\/\/doi.org\/10.7326\/AITC202006020","journal-title":"Ann Intern Med"},{"issue":"2","key":"8476_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/BOR.0000000000000865","volume":"34","author":"F Szelinski","year":"2022","unstructured":"Szelinski F, Lino AC, D\u00f6rner T (2022) B cells in systemic lupus erythematosus. Curr Opin Rheumatol 34(2):125\u2013132. https:\/\/doi.org\/10.1097\/BOR.0000000000000865","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"8476_CR4","doi-asserted-by":"publisher","first-page":"13084","DOI":"10.3390\/ijms160613084","volume":"16","author":"K Ma","year":"2015","unstructured":"Ma K, Li J, Fang Y, Lu L (2015) Roles of B cell-intrinsic TLR signals in systemic lupus erythematosus. Int J Mol Sci 16(6):13084\u201313105. https:\/\/doi.org\/10.3390\/ijms160613084","journal-title":"Int J Mol Sci"},{"issue":"4","key":"8476_CR5","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/art.40396","volume":"70","author":"S Karrar","year":"2018","unstructured":"Karrar S, Cunninghame Graham DS (2018) Abnormal B cell development in systemic lupus erythematosus: what the genetics tell us. Arthritis Rheumatol 70(4):496\u2013507. https:\/\/doi.org\/10.1002\/art.40396","journal-title":"Arthritis Rheumatol"},{"key":"8476_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102873","volume":"132","author":"L Arbitman","year":"2022","unstructured":"Arbitman L, Furie R, Vashistha H (2022) B cell-targeted therapies in systemic lupus erythematosus. J Autoimmun 132:102873. https:\/\/doi.org\/10.1016\/j.jaut.2022.102873","journal-title":"J Autoimmun"},{"issue":"1","key":"8476_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-023-00139-x","volume":"4","author":"L Qiu","year":"2023","unstructured":"Qiu L, Jing Q, Li Y, Han J (2023) RNA modification: mechanisms and therapeutic targets. Mol Biomed 4(1):25. https:\/\/doi.org\/10.1186\/s43556-023-00139-x","journal-title":"Mol Biomed"},{"issue":"1","key":"8476_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02255-4","volume":"24","author":"Y Ji","year":"2025","unstructured":"Ji Y, Xiao C, Fan T, Deng Z, Wang D, Cai W et al (2025) The epigenetic hallmarks of immune cells in cancer. Mol Cancer 24(1):66. https:\/\/doi.org\/10.1186\/s12943-025-02255-4","journal-title":"Mol Cancer"},{"key":"8476_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-immunol-101921-045401","volume":"41","author":"D Han","year":"2023","unstructured":"Han D, Xu MM (2023) RNA modification in the immune system. Annu Rev Immunol 41:73\u201398. https:\/\/doi.org\/10.1146\/annurev-immunol-101921-045401","journal-title":"Annu Rev Immunol"},{"key":"8476_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1706984","volume":"16","author":"Q Wang","year":"2026","unstructured":"Wang Q, Jiang X, Yuan Y, Li C (2026) The emerging roles of METTL1-mediated tRNA m7G methylation in cancer development and immunotherapy. Front Immunol 16:1706984. https:\/\/doi.org\/10.3389\/fimmu.2025.1706984","journal-title":"Front Immunol"},{"issue":"2","key":"8476_CR11","doi-asserted-by":"publisher","first-page":"e70240","DOI":"10.1002\/ctm2.70240","volume":"15","author":"H Fang","year":"2025","unstructured":"Fang H, He J, Du D, Wang X, Xu X, Lu L et al (2025) Deciphering the secret codes in N7-methylguanosine modification: context-dependent function of methyltransferase-like 1 in human diseases. Clin Transl Med 15(2):e70240. https:\/\/doi.org\/10.1002\/ctm2.70240","journal-title":"Clin Transl Med"},{"issue":"1","key":"8476_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54941-4","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang S, Han H, Qian Y, Ruan X, Lin Z, Li J et al (2024) Aberrant METTL1-mediated tRNA m7G modification alters B-cell responses in systemic autoimmunity in humans and mice. Nat Commun 15(1):10599. https:\/\/doi.org\/10.1038\/s41467-024-54941-4","journal-title":"Nat Commun"},{"issue":"3","key":"8476_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ard.2025.09.010","volume":"85","author":"S Chen","year":"2025","unstructured":"Chen S, Sun K, Peng C, Kuang Y, Zhang S, Li R et al (2025) METTL1-mediated internal m7G methylation of cathepsin B mRNA promotes synovial aggression in rheumatoid arthritis. Ann Rheum Dis 85(3):435\u2013446. https:\/\/doi.org\/10.1016\/j.ard.2025.09.010","journal-title":"Ann Rheum Dis"},{"issue":"Pt 1","key":"8476_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.149196","volume":"335","author":"Y Xu","year":"2025","unstructured":"Xu Y, Liu W, Zai Z, Qian X, Hu W, Peng X et al (2025) H3K18la-driven methyltransferase 1-mediated upregulation of NeuroD1 m7G modification in promoting ferroptosis resistance in rheumatoid arthritis synovial fibroblasts. Int J Biol Macromol 335(Pt 1):149196. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149196","journal-title":"Int J Biol Macromol"},{"key":"8476_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.03.1157","author":"Q Zhen","year":"2019","unstructured":"Zhen Q, Yang Z, Wang W, Li B, Bai M, Wu J et al (2019) Genetic study on small insertions and deletions in psoriasis reveals a role in complex human diseases. J Invest Dermatol. https:\/\/doi.org\/10.1016\/j.jid.2019.03.1157","journal-title":"J Invest Dermatol"},{"issue":"11","key":"8476_CR16","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1007\/s00415-019-09476-w","volume":"266","author":"X-B Mo","year":"2019","unstructured":"Mo X-B, Lei S-F, Qian Q-Y, Guo Y-F, Zhang Y-H, Zhang H (2019) Integrative analysis revealed potential causal genetic and epigenetic factors for multiple sclerosis. J Neurol 266(11):2699\u20132709. https:\/\/doi.org\/10.1007\/s00415-019-09476-w","journal-title":"J Neurol"},{"issue":"9","key":"8476_CR17","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R et al (2019) 2019 European league against Rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 71(9):1400\u20131412. https:\/\/doi.org\/10.1002\/art.40930","journal-title":"Arthritis Rheumatol"},{"key":"8476_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110155","volume":"119","author":"Y Yang","year":"2023","unstructured":"Yang Y, Li M, Zhu Y, Liu K, Liu M, Liu Y et al (2023) EZH2 inhibition dampens autoantibody production in lupus by restoring B cell immune tolerance. Int Immunopharmacol 119:110155. https:\/\/doi.org\/10.1016\/j.intimp.2023.110155","journal-title":"Int Immunopharmacol"},{"key":"8476_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14020451","author":"Y Yang","year":"2026","unstructured":"Yang Y, Liu K, Ma H, Lu L, Zhu G, Zuo X et al (2026) Upregulated ZBP1 is associated with b-cell dysregulation in systemic lupus erythematosus. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines14020451","journal-title":"Biomedicines"},{"issue":"2","key":"8476_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12016-020-08820-7","volume":"62","author":"Y Nie","year":"2021","unstructured":"Nie Y, Zhao L, Zhang X (2021) B cell aberrance in lupus: the ringleader and the solution. Clin Rev Allergy Immunol 62(2):301\u2013323. https:\/\/doi.org\/10.1007\/s12016-020-08820-7","journal-title":"Clin Rev Allergy Immunol"},{"key":"8476_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2025.103438","volume":"154","author":"HJ van Dooren","year":"2025","unstructured":"van Dooren HJ, Atisha-Fregoso Y, Dorj\u00e9e AL, Huizinga TWJ, Mackay M, Aranow C et al (2025) Interferon signatures fuel B cell hyperactivity and plasmablast expansion in systemic lupus erythematosus. J Autoimmun 154:103438. https:\/\/doi.org\/10.1016\/j.jaut.2025.103438","journal-title":"J Autoimmun"},{"issue":"5","key":"8476_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41584-026-01365-7","volume":"22","author":"DY-D Zhu","year":"2026","unstructured":"Zhu DY-D, Castrillon C, Akama-Garren E, Carroll MC (2026) Germinal-centre and extrafollicular B cell pathways in systemic lupus erythematosus. Nat Rev Rheumatol 22(5):285\u2013301. https:\/\/doi.org\/10.1038\/s41584-026-01365-7","journal-title":"Nat Rev Rheumatol"},{"key":"8476_CR23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20231882","author":"AJ Fike","year":"2025","unstructured":"Fike AJ, Bricker KN, Gonzalez MV, Maharjan A, Bui T, Nuon K et al (2025) IRF7 controls spontaneous autoimmune germinal center and plasma cell checkpoints. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20231882","journal-title":"J Exp Med"},{"key":"8476_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00427","volume":"9","author":"S Malkiel","year":"2018","unstructured":"Malkiel S, Barlev AN, Atisha-Fregoso Y, Suurmond J, Diamond B (2018) Plasma cell differentiation pathways in systemic lupus erythematosus. Front Immunol 9:427. https:\/\/doi.org\/10.3389\/fimmu.2018.00427","journal-title":"Front Immunol"},{"issue":"7","key":"8476_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nri.2017.24","volume":"17","author":"DJ Rawlings","year":"2017","unstructured":"Rawlings DJ, Metzler G, Wray-Dutra M, Jackson SW (2017) Altered B cell signalling in autoimmunity. Nat Rev Immunol 17(7):421\u2013436. https:\/\/doi.org\/10.1038\/nri.2017.24","journal-title":"Nat Rev Immunol"},{"key":"8476_CR26","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20231314","author":"J Deguine","year":"2024","unstructured":"Deguine J, Xavier RJ (2024) B cell tolerance and autoimmunity: lessons from repertoires. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20231314","journal-title":"J Exp Med"},{"issue":"1","key":"8476_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01175-9","volume":"7","author":"L Cui","year":"2022","unstructured":"Cui L, Ma R, Cai J, Guo C, Chen Z, Yao L et al (2022) RNA modifications: importance in immune cell biology and related diseases. Signal Transduct Target Ther 7(1):334. https:\/\/doi.org\/10.1038\/s41392-022-01175-9","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"8476_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01777-5","volume":"9","author":"W-W Liu","year":"2024","unstructured":"Liu W-W, Zheng S-Q, Li T, Fei Y-F, Wang C, Zhang S et al (2024) RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy. Signal Transduct Target Ther 9(1):70. https:\/\/doi.org\/10.1038\/s41392-024-01777-5","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"8476_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41590-020-0650-4","volume":"21","author":"Z Shulman","year":"2020","unstructured":"Shulman Z, Stern-Ginossar N (2020) The RNA modification N6-methyladenosine as a novel regulator of the immune system. Nat Immunol 21(5):501\u2013512. https:\/\/doi.org\/10.1038\/s41590-020-0650-4","journal-title":"Nat Immunol"},{"key":"8476_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216165","volume":"562","author":"D Du","year":"2023","unstructured":"Du D, He J, Ju C, Wang C, Li H, He F et al (2023) When N7-methyladenosine modification meets cancer: emerging frontiers and promising therapeutic opportunities. Cancer Lett 562:216165. https:\/\/doi.org\/10.1016\/j.canlet.2023.216165","journal-title":"Cancer Lett"},{"issue":"10","key":"8476_CR31","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","volume":"5","author":"ZE Stine","year":"2015","unstructured":"Stine ZE, Walton ZE, Altman BJ, Hsieh AL, Dang CV (2015) MYC, metabolism, and cancer. Cancer Discov 5(10):1024\u20131039. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0507","journal-title":"Cancer Discov"},{"key":"8476_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103756","volume":"75","author":"V Llombart","year":"2021","unstructured":"Llombart V, Mansour MR (2021) Therapeutic targeting of \u201cundruggable\u201d MYC. EBioMedicine 75:103756. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103756","journal-title":"EBioMedicine"},{"key":"8476_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-5-22","volume":"5","author":"S-S Han","year":"2006","unstructured":"Han S-S, Peng L, Chung S-T, DuBois W, Maeng S-H, Shaffer AL et al (2006) CDDO-Imidazolide inhibits growth and survival of c-Myc-induced mouse B cell and plasma cell neoplasms. Mol Cancer 5:22","journal-title":"Mol Cancer"},{"issue":"7","key":"8476_CR34","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.4049\/jimmunol.2100440","volume":"207","author":"DG Patterson","year":"2021","unstructured":"Patterson DG, Kania AK, Price MJ, Rose JR, Scharer CD, Boss JM (2021) An IRF4-MYC-mTORC1 integrated pathway controls cell growth and the proliferative capacity of activated B cells during B cell differentiation in vivo. J Immunol 207(7):1798\u20131811. https:\/\/doi.org\/10.4049\/jimmunol.2100440","journal-title":"J Immunol"},{"issue":"7","key":"8476_CR35","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.ccell.2024.05.026","volume":"42","author":"A Bolomsky","year":"2024","unstructured":"Bolomsky A, Ceribelli M, Scheich S, Rinaldi K, Huang DW, Chakraborty P et al (2024) IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma. Cancer Cell 42(7):1185\u20131201. https:\/\/doi.org\/10.1016\/j.ccell.2024.05.026","journal-title":"Cancer Cell"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08476-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08476-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08476-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:32:47Z","timestamp":1791847967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08476-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":35,"alternative-id":["8476"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08476-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"9 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}}]}}